Lexaria Bioscience Corp (LEXX)

[damAcon1]

You're right, given the insiders that hold this stock, the decision is already made. We both know dilution is gonna happen, because of what you said, let's hope they pair it with FDA IND news and take it at the highs. The problem is that adding an RS is not a vote of confidence to anyone holding this stock. It is more an indicator that things aren't progressing as smooth as the company is trying to portray (and not because they can't control the 3rd party stability testing...but as an "in general"). They keep saying we have enough cash for a year. Then they say we need to raise for additional testing...they do it and again say they are good for another year. But now this? Where are all the interesting parties in licensing this? I am obviously waiting for the IND news...but I am really hoping that the govt reschedules cannabis and forces the hand of some pharma company to buy them out, given their patent portfolio and vast CBD research.